This Day On The Street
Continue to site right-arrow
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
$1 buys you full access to ALL of TheStreet's Subscription Services! Learn More
Cytori Therapeutics Inc
CYTX : NASDAQ : Health Care
$0.41 | %
Today's Range: 0.41 - 0.47
Avg. Daily Volume: 1,185,700
11/21/14 - 3:59 PM ET

PEER GROUP: Biotechnology

Ticker Company Name Recent
Net Sales
Net Income
CYTX CYTORI THERAPEUTICS INC 0.45 41.60 n/m 7.29 -54.62
AVEO AVEO PHARMACEUTICALS INC 0.96 50.16 n/m 17.78 3.40
CLSN CELSION CORP 2.47 49.34 n/m 0.50 100.00
ENZN ENZON PHARMACEUTICALS INC 1.09 48.11 1.82 33.00 -17.53
OGXI ONCOGENEX PHARMACEUTICALS 2.15 45.75 n/m 30.07 -3.20
APPY VENAXIS INC 1.38 42.77 n/m 0.20 194.11
GNVC GENVEC INC 1.93 33.33 n/m 3.99 -28.86
OGEN ORAGENICS INC 0.88 31.84 n/m 1.21 16.07
RXII RXI PHARMACEUTICALS CORP 1.87 30.11 n/m 0.16 -56.80
XTLB XTL BIOPHARMACEUTICALS 2.45 29.05 n/m 2.15 1.31
OPXA OPEXA THERAPEUTICS INC 0.89 25.08 n/m 1.36 138.13
The peer group comparison is based on Major Biotechnology companies of comparable size.

Price Earnings Comparison

CYTX Ind Avg S&P 500
n/m 61.84 19.78

Select the service that is right for you!

Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV

Latest Stock Upgrades/Downgrades

Top Rated Stocks Top Rated Funds Top Rated ETFs